FDA Submits Proposal for Review of Information Collection Activities

Summary

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, as part of a request for industry guidance on nonproprietary naming of biological products.